pferde spiegel, Table of Contents pferde spiegel 2021; 24(02): 70-79DOI: 10.1055/a-1380-6032 CVE-Fortbildung Die transvenöse elektrische Kardioversion (TVEC) bei Pferden mit Vorhofflimmern Tobias Niebuhr , Bernhard Ohnesorge Recommend Article Abstract Buy Article All articles of this category Vorhofflimmern ist die bei Pferden am häufigsten auftretende, klinisch relevante Arrhythmie. Neben der Behandlung mit Chinidinsulfat ist die transvenöse elektrische Kardioversion eine erfolgversprechende Therapieoption. Full Text References Literatur 1 Reef VB, Levitan CW, Spencer PA. Factors affecting prognosis and conversion in equine atrial fibrillation. J Vet Intern Med 1988; 2: 1-6 2 Reef VB, Reimer JM, Spencer PA. Treatment of atrial fibrillation in horses: New perspectives. J Vet Intern Med 1995; 9: 57-67 3 Physick-Sheard PW. Atrial fibrillation. In: Colahan PT, Mayhew IG, Merritt AM, Moore JN. eds. Equine Medicine and Surgery, 5th ed. St. Louis, Mo: Mosby; 1999: 354-358 4 Reef V, Bonagura J, Buhl R, McGurrin M, Schwarzwald C, van Loon G, Young L. Recommendations for Management of Equine Athletes with Cardiovascular Abnormalities. J Vet Intern Med 2014; 28: 749-761 5 Niebuhr T, Ohnesorge B. Management von Reitpferden mit Herzerkrankungen – Empfehlungen von ECEIM, ACVIM und Consensus Statement. Pferdespiegel 2020; 23 (04) 178-188 6 Kimberly M, McGurrin J, Physick-Sheard PW, Kenney DJ, Kerr C, Hanna B, Neto F, Weese S. Transvenous electrical cardioversion in atrial fibrillation: technique and successful treatment of 3 horses. J Vet Intern Med 2003; 17: 715-718 7 Kimberly M, McGurrin J, Physick-Sheard PW, Kenney DG. How to perform transvenous electrical cardioversion in horses with atrial fibrillation. J Vet Cardiol 2005; 7: 109-119 8 McGurrin M, Physick-Sheard P, Kenney D. Transvenous Electrical Cardioversion of Equine Atrial Fibril-lation: Patient Factors and Clinical Results in 72 Treatment Episodes. J Vet Intern Med 2008; 22: 609-615 9 Kimberly M, McGurrin J, Physick-Sheard PW, Kenney DG, Kerr C, Hanna WB. Transvenous Electrical Cardioversion of Equine Atrial Fibrillation Technical Considerations. J Vet Intern Med 2005; 19: 695-702 10 Preiss E, Kenney DG, Kimberly M, McGurrin J, Physick-Sheard PW. Influence of electrode position on cardioversion energy requirements during transvenous electrical cardioversion in horse. Am J Vet Res 2011; 72 (09) 1193-1203 11 De Clercq D, van Loon G, Schauvliege S. et al. Transvenous electrical cardioversion of atrial fibrillation in six horses using custom made cardioversion catheters. Vet J 2008; 177: 198-204 12 Bellei MH, Kerr C, McGurrin MK. et al. Management and complications of anesthesia for transvenous electrical cardioversion of atrial fibrillation in horses: 62 cases (2002–2006). J Am Vet Med Assoc 2007; 231: 1225-1230 13 Decloedt A VT, Van Der Vekens N, De Clercq D, van Loon G. Long-term follow-up of atrial function after cardioversion of atrial fibrillation in horses. Vet J 2013; 197: 583-588 14 Schwarzwald CC, Schober KE, Bonagura JD. Echocardiographic evidence of left atrial mechanical dys-function after conversion of atrial fibrillation to sinus rhythm in 5 horses. J Vet Intern Med 2007; 21: 820-827 15 De Clercq D, Decloedt A, Sys S, Verheyen T, Van Der Vekens N, van Loon G. Atrial Fibrillation Cycle Length and Atrial Size in Horses with and without Recurrence of Atrial Fibrillation after Electrical Cardio-version. J Vet Intern Med 2014; 28: 624-629 16 Vernemmen I, De Clercq D, Decloedt A, Vera L, Van Steenkiste G, van Loon G. Atrial premature depolarisations five days post electrical cardioversion are related to atrial fibrillation recurrence risk in horses. Equine Vet J 2020; 52: 374-378 17 Decloedt A, Schwarzwald CC, De Clercq D, Van Der Vekens N, Pardon B, Reef VB, van Loon G. Risk factors for recurrence of atrial fibrillation in horses after cardioversion to sinus rhythm. J Vet Intern Med 2015; 29 (03) 946-953 18 Decloedt A, Verheyen T, Van Der Vekens N, Sys S, De Clercq D, van Loon G. Long-term follow-up of atrial function after cardioversion of atrial fibrillation in horses. Vet J 2013; 197 (03) 583-588 19 Neuckermans Z. et al. Amiodarone during transvenous electrical cardioversion of atrial fibrillation in horses to reduce cardioversion threshold or prevent immediate recurrence. 13th ECEIM Congress; 2020 20 Marly-Voquer C, Schwarzwald CC, Bettschart-Wolfensberger R. The use of dexmedetomidine continuous rate infusion for horses undergoing transvenous electrical cardioversion-A case series. Can Vet J 2016; 57 (01) 70-75 21 Decloedt A, Broux B, De Clercq D, Deprez P, Van Steenkiste G, Vera L, van Loon G. Effect of sotalol on heart rate, QT interval, and atrial fibrillation cycle length in horses with atrial fibrillation. J Vet Intern Med 2018; 32 (02) 815-821 22 Dufourni A, Broux B, Decloedt A, De Clercq D, van Loon G. Influence of orally administered sotalol hydrochloride on QT intervals at rest and in anesthetized horses after transvenous electrical cardioversion (TVEC). 9th Congress of the European College of Equine Internal Medicine; 2016: 104 23 Schwarzwald CC, Schober KE, Bonagura JD. Methods and reliability of echocardiographic as-sessment of left atrial size and mechanical function in horses. Am J Vet Res 2007; 68 (07) 735-747 24 Jesty S, Kraus M, Gelzer A, Rishniw M, Moïse N. Effect of Transvenous Electrical Cardioversion on Plasma Cardiac Troponin I Concentrations in Horses with Atrial Fibrillation. J Vet Intern Med 2009; 23: 1103-1107
